Presentations: Codeine up-scheduling workshops, Melbourne, 28 November 2017

6 December 2017

The TGA held a series of workshops on the up-scheduling of codeine in November 2017. Below are the presentations from the Melbourne workshop.

For further information about changes to medicines containing codeine, see the Codeine information hub.

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

How to access a pdf document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.

Delivering pain management in a rural setting

  • Presented by: Dr Malcolm Hogg, Royal Melbourne Hospital and Head of Pain Services, Melbourne Health
  • Presented at: TGA workshop: Codeine up-scheduling, 28 November 2017
  • Presentation summary: This presentation gives an overview of delivering pain management in a rural setting.

Presentation: Delivering pain management in a rural setting (pdf,1.45Mb)*

Over the counter, down the hatch: OTC codeine use

  • Presented by: Dr Matthew Frei, Head, Drug and Alcohol, Monash University
  • Presented at: TGA workshop: Codeine up-scheduling, 28 November 2017
  • Presentation summary: This presentation provides an overview of OTC Codeine usage and pharmaceutical opioid addiction.

Presentation: Over the counter, down the hatch: OTC codeine use (pdf,715kb)*

Pain - rethinking our approach to pain and the role of opioid therapy

  • Presented by: Dr Malcolm Hogg, Royal Melbourne Hospital and Head of Pain Services, Melbourne Health
  • Presented at: TGA workshop: Codeine up-scheduling, 28 November 2017
  • Presentation summary: This presentation provides an overview of current approaches to pain management.

Presentation: Pain - rethinking our approach to pain and the role of opioid therapy (pdf,3.04Mb)*

Alternative options to codeine in the pharmacy

  • Presented by: Pene Wood, Opioid Management Team lead
  • Presented at: TGA workshop: Codeine up-scheduling, 28 November 2017
  • Presentation summary: This presentation provides an overview of alternative options to codeine in pain management.

Presentation: Alternative options to codeine in the pharmacy (pdf,164kb)

Additional communication and education activities to support the transition of codeine from over-the-counter to prescription only

  • Presented by: Avi Rebera, Assistant Secretary, Regulatory Education and Planning, Health Product Regulation Group, Department of Health
  • Presented at: TGA workshop: Codeine up-scheduling, 28 November 2017
  • Presentation summary: This presentation provides an overview of the communication and education activities being supported by the government as part of the transition for the up-scheduling of codeine.

Presentation: Additional communication and education activities to support the transition of codeine from over-the-counter to prescription only (pdf,242kb)

Changes to codeine product access

  • Presented by: Adj Prof John Skerritt, Deputy Secretary for Health Product Regulation, Department of Health
  • Presented at: TGA workshop: Codeine up-scheduling, 28 November 2017
  • Presentation summary: This presentation provides an overview of the background to the decision to up-schedule codeine-containing compounds.

Presentation: Changes to codeine product access (pdf,515kb)*